Previous results showed that the patients who had autoantibodies against β-cell, including GAD antibodies, IAAs, insulinoma antigen-2 antibodies, and islet cell antibodies, more likely presented DKA and within shorter time intervals from ICI therapy (12, 13). Here, GAD1 is linked to pancreatic insulinoma.